Mounjaro & Zepbound Hair Loss: What Women Should Know About Tirzepatide Shedding

By Shaharazad, Chemist & Founder, Kamilah Already®

Mounjaro and Zepbound have helped so many women take back their health: steadier blood sugar, real progress on the scale, and a body that finally feels like it's working with them.

So when your ponytail starts feeling thinner a few months in, or you're pulling more hair out of your brush than ever, it can feel deeply unfair. You're doing everything right. Why is your hair paying the price?

If that's you, take a breath. You're not imagining it, you're not alone, and you didn't do anything wrong. Here's what the research shows about hair loss on tirzepatide, why women are affected so much more often, and what actually helps.

I'm a formulating chemist who has spent my career in haircare, not a physician. My goal is to give you the science in plain language so you can have a better conversation with your doctor.

First, you did nothing wrong

Choosing to take care of your health takes courage. Hair changes can feel discouraging, but they don't cancel out the strength of that choice or the progress you're making.

Shedding during a big body change is usually a sign that your body is adapting, not failing. Understanding why it happens is the first step toward feeling in control again.

How common is hair loss on Mounjaro and Zepbound?

Mounjaro and Zepbound are both brand names for tirzepatide. Mounjaro is approved for type 2 diabetes and Zepbound for weight management. Hair loss is listed in Zepbound's FDA prescribing information:

• About 4 to 5% of people taking Zepbound in the pivotal weight-loss trials reported hair loss, compared with 1% on placebo.
• Women reported it far more often: 7.1% of women compared with 0.5% of men.
• The label says hair loss in these trials was associated with weight reduction.
• No one taking Zepbound in those trials stopped the medication because of hair loss.

Those numbers say two important things. Hair loss is real and worth planning for, and for most women it's a side effect they can get through.

Why tirzepatide seems to cause more shedding than other GLP-1s

Tirzepatide is the most powerful weight-loss medication in its class. In the SURMOUNT-1 trial, people lost an average of 15% to 21% of their body weight over 72 weeks, depending on dose. That's more than semaglutide (Ozempic and Wegovy) typically produces.

Rapid, significant weight loss is a well-known trigger for telogen effluvium (TE), a temporary, all-over shedding. Your body treats fast weight loss as a stressor, even when it's intentional and healthy. A large share of hair follicles shift into their resting phase at the same time, and about two to three months later, those hairs shed together.

The research lines up with this:

• In a 2025 study in the Journal of the American Academy of Dermatology, tirzepatide users had a higher risk of TE than people on other weight-loss medications. Their risk was comparable to people who'd had bariatric surgery, which is a well-known cause of TE.
• A 2026 study comparing tirzepatide with semaglutide found new hair loss in 4.24% versus 3.33% of patients, even after matching for how much weight they lost. Among women, it was 5.44% versus 3.63%. That study hasn't completed peer review yet, and researchers are still working out what else, beyond weight loss, might explain the difference.

Want the full story on why the shedding shows up months after you start? Read our deep dive on delayed GLP-1 shedding.

Why are women affected so much more?

Researchers don't have a final answer yet, but several factors likely stack together:

• Women tend to lose more weight on GLP-1s than men, according to a 2025 meta-analysis, and bigger, faster loss is the main TE trigger.
• Women may develop TE at lower rates of weight loss than men, so the same pace can affect your hair more.
• Women are more likely to be eating very little on these medications, which means less protein and fewer of the nutrients hair is built from.
• Lower iron stores are common in women, and low ferritin is one of the most frequent contributors to shedding.
• Hormonal sensitivity. Hair follicles respond to estrogen, and rapid metabolic change may shift hormonal signals. A 2026 review in Science Progress concluded that early shedding on GLP-1s is still more likely driven by fast weight loss and calorie or protein gaps than by hormones.
• Women notice and report hair changes more, which affects the numbers too.

The part nobody talks about: unmasking

Sometimes a wave of shedding uncovers thinning that was already developing quietly, like female pattern hair loss. If your thinning concentrates at the crown or along a widening part, rather than evenly all over, it's worth a dermatology visit. That's a different process with different options.

Some studies have also found higher rates of pattern hair loss in people taking GLP-1s, including tirzepatide. Those findings come from medical-record studies that can't prove cause and effect. They're one more reason to get thinning evaluated rather than wait.

And research doesn't only point one way. In a 2025 study of patients with central centrifugal cicatricial alopecia (CCCA), a scarring hair loss that most often affects Black women, 42% of those taking GLP-1 medications showed improvement. Researchers think better metabolic health may calm scalp inflammation. It's early, but it's a reminder that the relationship between these medications and hair is still being written.

Not sure what's behind your shedding? Take my 60-second hair quiz, and I'll send you the science that fits your situation.

Is hair loss from Mounjaro or Zepbound permanent?

For most women, no. Telogen effluvium is temporary because the follicle isn't damaged; it's resting. Shedding usually eases within a few months of your weight and eating stabilizing, and improvement is generally seen within 3 to 6 months after that.

New hair grows slowly. It starts as fine, short strands, often along your part or hairline, and takes months to add visible length and fullness. Patience really is part of the plan.

What helps while you're on tirzepatide

1. Protein first. Hair is built from keratin, a protein. A 2025 joint nutrition advisory for GLP-1 users lists about 80 to 120 grams of protein a day as a practical range for many adults during weight loss. Confirm your number with your care team, and eat your protein first at meals, before you fill up.

2. Get your labs checked. Ask about a complete blood count, ferritin (iron stores), vitamin D, B12 and thyroid levels. Fix real gaps instead of guessing. If you take biotin, tell your doctor first, because high doses can distort lab results.

3. Talk with your prescriber about pace. If shedding is heavy or you can't eat enough protein, bring it up. Your dose schedule is a medical decision, so please don't change or skip doses on your own.

4. Ease up on tension. Tight braids, slick ponytails and tight wig or unit attachments pull on your edges at a time when your hair has less margin. Choose looser styles for a few months.

5. Keep a simple, consistent scalp routine. Your scalp is where your hair lives. A lightweight daily routine that doesn't leave heavy buildup gives you a comfortable scalp and something steady to do while your body catches up.

That's why I formulated the Edge Back Hair Serum. It's water-based, oil-free and fragrance-free, made with seven botanicals (bamboo, hibiscus, rosemary, caffeine, green tea, lavender and pumpkin seed) chosen to support a healthier-looking scalp. One step, once a day, no rinsing. With consistent use, it's designed to support fuller-looking hair over time. Give it a full 90 days of daily use before you judge.

Individual results vary. Daily use is required for optimal results.

When to see a dermatologist

• Shedding lasts longer than 6 to 9 months.
• You notice patterned thinning, like a widening part or thinner crown.
• Your scalp itches, burns, feels tender or looks inflamed. These can be signs of a scarring hair loss like CCCA, which needs prompt care.
• You see distinct bald patches.

A gentle reminder

Hair loss in the middle of a health transformation can feel unfair, especially when you're doing everything right. But for most women, it's a temporary chapter, not the end of the story.

With time, nourishment and steady care, your health journey and your hair journey can coexist, and both deserve care.

Save this for month three, and send it to a friend on Mounjaro or Zepbound.

Find out what's really behind your thinning

Take my 60-second hair quiz, and I'll send you a short email series that goes deeper on hair shedding during weight loss.

Take the 60-second quiz →

Frequently asked questions

Does Mounjaro cause hair loss?

Mounjaro and Zepbound contain the same medication, tirzepatide. In Zepbound's weight-loss trials, about 4 to 5% of participants reported hair loss, compared with 1% on placebo. The label says it was associated with weight reduction.

Why is hair loss on Zepbound more common in women?

In the trials, 7.1% of women reported hair loss compared with 0.5% of men. Likely reasons include greater weight loss in women, lower food intake, lower iron stores, and hormonal sensitivity of hair follicles.

When does hair loss start on Zepbound?

Weight-loss-related shedding usually appears about two to three months after starting tirzepatide or increasing the dose, because that's how long resting hairs take to release.

Will my hair come back after Mounjaro or Zepbound?

For most women, yes. The most common type, telogen effluvium, doesn't damage the follicle. Improvement is generally seen within months once weight and nutrition stabilize. See a dermatologist if shedding lasts beyond 6 to 9 months or follows a pattern.

Sources

1. Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.
2. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine, 2022.
3. Increased risk of telogen effluvium with tirzepatide compared to other weight loss medications: a retrospective cohort TriNetX database study. Journal of the American Academy of Dermatology, 2025.
4. New-onset alopecia is significantly higher with tirzepatide than with semaglutide, even after weight-loss matching. Preprints.org, 2026 (not yet peer-reviewed).
5. GLP-1 therapies and hair loss: a systematic review of current evidence and implications for counseling. Science Progress, 2026.
6. Sex differences in the efficacy of glucagon-like peptide-1 receptor agonists for weight reduction: a systematic review and meta-analysis. Journal of Diabetes, 2025.
7. Association between androgenetic alopecia and glucagon-like peptide-1 receptor treatment in type 2 diabetes mellitus patients. International Journal of Dermatology, 2025.
8. GLP-1 agonists may modulate treatment efficacy in central centrifugal cicatricial alopecia. Journal of the American Academy of Dermatology, 2025.
9. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity, 2025.
10. Biotin supplements can interfere with cardiac troponin tests: FDA. TCTMD.

---

This article is for educational purposes only and is not medical advice. Talk with your prescriber or a board-certified dermatologist about your specific situation.

Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Kamilah Already is not affiliated with, sponsored by, or endorsed by either company.